TARRYTOWN, N.Y. and PARIS, Sept. 15, 2018 /PRNewswire/ --
Results on skin clearing, itch and certain quality of life measurements were presented today as a late-breaking
Growth Capitalist (https://growthcapitalist.com/2018/09/positive-phase-3-results-presented-for-dupixent-dupilumab-show-significant-improvement-on-multiple-measures-of-disease-severity-in-adolescents-with-moderate-to-severe-atopic-dermatitis/)
TARRYTOWN, N.Y. and PARIS, Sept. 15, 2018 /PRNewswire/ --
Results on skin clearing, itch and certain quality of life measurements were presented today as a late-breaking